Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients

Journal of Neuroimmunology

Volumn 244, Issue 1-2, 2012, Pages 94-96

  Wen, Shi Rong ^a   Liu, Guo Jun ^a   Feng, Ren Nan ^a   Gong, Feng Chao ^a   Zhong, Hua ^a   Duan, Shu Rong ^a   Bi, Sheng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

IL 23; Multiple sclerosis; Osteopontin

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN TARGETING;

ADULT; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-23; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; OSTEOPONTIN; YOUNG ADULT;

EID: 84862831210     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.12.004     Document Type: Article

References (17)

1. Bornsen L., Khademi M., Olsson T., Sorensen P.S., Sellebjerg F. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis. Mult. Scler. 2011, 17:32-42.
2. Braitch M., Nunan R., Niepel G., Edwards L.J., Constantinescu C.S. Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis. Arch. Neurol. 2008, 65:633-635.
3. Chiocchetti A., Comi C., Indelicato M., Castelli L., Mesturini R., Bensi T., Mazzarino M.C., Giordano M., D'Alfonso S., Momigliano-Richiardi P., Liguori M., Zorzon M., Amoroso A., Trojano M., Monaco F., Leone M., Magnani C., Dianzani U. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J. Neuroimmunol. 2005, 163:172-178.
4. Comabella M., Pericot I., Goertsches R., Nos C., Castillo M., Blas Navarro J., Rio J., Montalban X. Plasma osteopontin levels in multiple sclerosis. J. Neuroimmunol. 2005, 158:231-239.
5. Hunter S.F., Rodriguez M. Multiple sclerosis: a unique immunopathological syndrome of the central nervous system. Springer Semin. Immunopathol. 1995, 17:89-105.
6. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 2006, 116:1218-1222.
7. Krakauer M., Sorensen P., Khademi M., Olsson T., Sellebjerg F. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult. Scler. 2008, 14:622-630.
8. Lovett-Racke A.E., Yang Y., Racke M.K. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?. Biochim. Biophys. Acta 2011, 1812:246-251.
9. Pender M.P. The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?. J. Clin. Neurosci. 2004, 11:689-692.
10. Shin S.L., Cha J.H., Chun M.H., Chung J.W., Lee M.Y. Expression of osteopontin mRNA in the adult rat brain. Neurosci. Lett. 1999, 273:73-76.
11. Steinman L., Martin R., Bernard C., Conlon P., Oksenberg J.R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 2002, 25:491-505.
12. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
13. Vaknin-Dembinsky A., Murugaiyan G., Hafler D.A., Astier A.L., Weiner H.L. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 2008, 195:140-145.
14. Vogt M.H., Floris S., Killestein J., Knol D.L., Smits M., Barkhof F., Polman C.H., Nagelkerken L. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J. Neuroimmunol. 2004, 155:155-160.
15. Vogt M.H., Lopatinskaya L., Smits M., Polman C.H., Nagelkerken L. Elevated osteopontin levels in active relapsing-remitting multiple sclerosis. Ann. Neurol. 2003, 53:819-822.
16. Vogt M.H., Ten Kate J., Drent R.J., Polman C.H., Hupperts R. Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers. Mult. Scler. 2010, 16:443-449.
17. Weiner H.L. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 2004, 61:1613-1615.